Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 2
1(16.7%)
6Total
N/A(5)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT04545398Not ApplicableCompleted

Acute Meat and Alternative Intake (PRotEin DIet SatisfacTION Trial 3)

Role: collaborator

NCT04207372Not ApplicableCompleted

Protein Digestibility of Whey and Zein.

Role: collaborator

NCT03309254Not ApplicableCompleted

Role of Glycaemic Index and High Protein Meal in Response of Blood Biomarkers for Pre-diabetes

Role: collaborator

NCT03503552Completed

Body Composition and Risk for Development of Pre-diabetes in Post-menopausal Chinese Women in Singapore

Role: collaborator

NCT00283153Phase 2Completed

Affect Recognition: Enhancing Performance of Persons With Acquired Brain Injury (ABI)

Role: collaborator

NCT01796561Not ApplicableCompleted

The Effect of Olive Leaf Extract on Blood Pressure in Overweight Prehypertensives

Role: collaborator

NCT00659009Not ApplicableCompleted

Effects of Mild Hypobaric Hypoxia on Oxygen Saturation During Sleep

Role: collaborator

All 7 trials loaded